Text Size A A A

About Sun Pharma Laboratories Limited (SPLL)

Tell a Friend Print Home » Investors » About Sun Pharma Laboratories Limited (SPLL)

Sun Pharma Laboratories Limited ("SPLL" or "Company") is a pharmaceutical company having registered office in Mumbai, Maharashtra. The Company manufactures and markets pharmaceutical products in India. It was incorporated on January 17, 1997. On March 9, 2012, it became a wholly owned subsidiary of Sun Pharmaceutical Industries Limited (SPIL). The Domestic Formulation Undertaking of SPIL was transferred to the Company with effect from March 31, 2012, pursuant to the Scheme of Arrangement between Sun Pharmaceutical Industries Limited and the Company. The shares of the Company are not listed on any of the Stock Exchanges.

SPLL is engaged in the business of manufacturing and promoting Branded Generic pharmaceutical products and has a market share of 5.6% as per AIOCD AWACS ‐October 2015. The Company has four plants located in Sikkim and Jammu. It has strong foothold in the therapeutic segments of Neurology & Psychiatry, Central Nervous System, Cardiology, Gastroenterology, Diabetes, Gynecology etc. The Company is a market leader in India in the chronic segment, which contributes over 60% of its revenue as per AIOCD AWACS ‐October 2015. It offers a complete therapy basket with specialization in technically complex products. Among the country’s top 300 pharmaceutical brands, SPLL owns 19 brands. It has a strong field force of over 3,200 people who promote products to over 150,000 doctors across India. The field force has well-trained sales representatives with a strong track record of performance and enjoys one of the highest productivity amongst Indian pharmaceutical companies. The Company has consistently outperformed the average industry growth over years. As per February 2015 SMSRC report, the Company was ranked No.1 by prescriptions with 7 class of specialist doctors.

English